Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
Sarah R. Mudd(AbbVie (United States)), Julie L. Wilsbacher(AbbVie (United States)), Fritz G. Buchanan(AbbVie (United States)), Dong Cheng(AbbVie (United States)), Wenqing Gao(Queensland University of Technology), Min Cheng(Capital Medical University), Martin J. Voorbach(AbbVie (United States)), Jun Guo(AbbVie (United States)), Chris Tse(AbbVie (United States))
Cited by 3
Related Papers
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
|eLife|2012|2.1k
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
|Nature|2017|878
Phosphorylation of the MAP Kinase ERK2 Promotes Its Homodimerization and Nuclear Translocation
|Cell|1998|685
NK cell-based immunotherapy for malignant diseases
|Cellular and Molecular Immunology|2013|626